At BIO-Europe 2025 in Vienna, ReNewVax CEO Neil Murray sat down with BiotechTV’s Amy Brown to share how the company is advancing a next-generation, low-cost universal pneumococcal vaccine, targeting all 100 known serotypes of Streptococcus pneumoniae. “We’re confident...
We’re proud to share that ReNewVax CEO, Neil Murray, had his article published in Pharmaphorum, addressing one of the most urgent global health challenges of our time, antimicrobial resistance (AMR). Titled “When is the superbug message going to bite?”, the article...
ReNewVax are pleased to announce the appointment of Simon Thorn as Chief Financial Officer. An accomplished senior executive with significant expertise in the venture capital sector working hands-on with SME’s to help them to scale, prior to joining ReNewVax, Simon...
ReNewVax has been included in the “Northern Life Sciences” supplement published by City AM. The supplement shines a spotlight on the achievements of the sector in the North, with features on this year’s Bionow Award winners and the important role that Bionow...
We were delighted to receive the award for Start-up of the year at last night’s Annual Bionow Awards Dinner. Commenting on the award, Neil Murray, ReNewVax’s CEO, said, “It’s a great honour to receive the Bionow Start-up of the Year Award. This is testament to the...
